Skip to main content
NCBI home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1977 Oct;74(10):4577–4581. doi: 10.1073/pnas.74.10.4577

Precursor role of arachidonic acid in release of slow reacting substance from rat basophilic leukemia cells.

B A Jakschik, S Falkenhein, C W Parker
PMCID: PMC431989  PMID: 22078

Abstract

The release of slow reacting substance (SRS) from rat basophilic leukemia cells (RBL-1) by the ionophore A23187 (5-10 mug/ml) was stimulated 5-fold by arachidonate and inhibited 78% by 5,8,11,14-eicosatetraynoate (an inhibitor of both fatty acid cyclooxygenase and lipoxygenase). Linoleic acid and linolenic acid both inhibited SRS formation, whereas indomethacin (a cyclooxygenase inhibitor) had no effect. Radiolabel from [14C]- or [3H]arachidonate was incorporated into SRS as indicated by comigration of radioactivity and bioreactivity in several chromatographic systems after purification to apparent radiochemical homogeneity. The radiolabeled SRS was clearly separated chromatographically from other known arachidonate metabolites. Thus, SRS appears to be a previously undescribed product of arachidonic acid metabolism, probably formed through the lipoxygenase pathway. The ability to prepare purified, biosynthetically labeled, SRS should be of considerable help in further studies of its structure, biologic function, and catabolism.

Full text

PDF
4577

Images in this article

4580Image
on p.4580

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Augstein J., Farmer J. B., Lee T. B., Sheard P., Tattersall M. L. Selective inhibitor of slow reacting substance of anaphylaxis. Nat New Biol. 1973 Oct 17;245(146):215–217. doi: 10.1038/newbio245215a0. [DOI] [PubMed] [Google Scholar]
  2. Bach M. K., Brashler J. R. In vivo and in vitro production of a slow reacting substance in the rat upon treatment with calcium ionophores. J Immunol. 1974 Dec;113(6):2040–2044. [PubMed] [Google Scholar]
  3. Bills T. K., Smith J. B., Silver M. J. Metabolism of [14C]arachidonic acid by human platelets. Biochim Biophys Acta. 1976 Feb 23;424(2):303–314. doi: 10.1016/0005-2760(76)90198-3. [DOI] [PubMed] [Google Scholar]
  4. Burka J. F., Eyre P. The immunological release of slow-reacting substance of anaphylaxis from bovine lung. Can J Physiol Pharmacol. 1974 Dec;52(6):1201–1204. doi: 10.1139/y74-156. [DOI] [PubMed] [Google Scholar]
  5. Conroy M. C., Orange R. P., Lichtenstein L. M. Release of slow reacting substance of anaphylaxis (SRS-A) from human leukocytes by the calcium ionophore A23187. J Immunol. 1976 Jun;116(6):1677–1681. [PubMed] [Google Scholar]
  6. Dawson W., Tomlinson R. Proceedings: Effect of cromoglycate and eicosatetraynoic acid on the release of prostaglandins and SRS-a from immunologically challenged guinea pig lungs. Br J Pharmacol. 1974 Sep;52(1):107P–108P. doi: 10.1111/j.1476-5381.1974.tb09695.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Eccleston E., Leonard B. J., Lowe J. S., Welford H. J. Basophilic leukaemia in the albino rat and a demonstration of the basopoietin. Nat New Biol. 1973 Jul 18;244(133):73–76. doi: 10.1038/newbio244073b0. [DOI] [PubMed] [Google Scholar]
  8. Engineer D. M., Piper P. J., Sirois P. Interaction between the release of SRS-A and of prostaglandins [proceedings]. Br J Pharmacol. 1976 Jul;57(3):460P–461P. [PMC free article] [PubMed] [Google Scholar]
  9. Flower R. J. Drugs which inhibit prostaglandin biosynthesis. Pharmacol Rev. 1974 Mar;26(1):33–67. [PubMed] [Google Scholar]
  10. Hamberg M., Samuelsson B. Prostaglandin endoperoxides. Novel transformations of arachidonic acid in human platelets. Proc Natl Acad Sci U S A. 1974 Sep;71(9):3400–3404. doi: 10.1073/pnas.71.9.3400. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Jakschik B. A., Kulczycki A., Jr, MacDonald H. H., Parker C. W. Release of slow reacting substance (SRS) from rat basophilic leukemia (RBL-1) cells. J Immunol. 1977 Aug;119(2):618–622. [PubMed] [Google Scholar]
  12. Kulczycki A., Jr, Metzger H. The interaction of IgE with rat basophilic leukemia cells. II. Quantitative aspects of the binding reaction. J Exp Med. 1974 Dec 1;140(6):1676–1695. doi: 10.1084/jem.140.6.1676. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Lewis R. A., Goetzl E. J., Wasserman S. I., Valone F. H., Rubin R. H., Austen K. F. The release of four mediators of immediate hypersensitivity from human leukemic basophils. J Immunol. 1975 Jan;114(1 Pt 1):87–92. [PubMed] [Google Scholar]
  14. Lewis R. A., Wasserman S. I., Goetzi E. J., Austen K. F. Formation of slow-reacting substance of anaphylaxis in human lung tissue and cells before release. J Exp Med. 1974 Nov 1;140(5):1133–1146. doi: 10.1084/jem.140.5.1133. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Liebig R., Bernauer W., Peskar B. A. Prostaglandin, slow-reacting substance, and histamine release from anaphylactic guinea-pig hearts, and its pharmacological modification. Naunyn Schmiedebergs Arch Pharmacol. 1975;289(1):65–76. doi: 10.1007/BF00498030. [DOI] [PubMed] [Google Scholar]
  16. Masuzawa Y., Osawa T., Inoue K., Nojima S. Effects of various mitogens on the phospholipid metabolism of human peripheral lymphocytes. Biochim Biophys Acta. 1973 Dec 20;326(3):339–344. [PubMed] [Google Scholar]
  17. Nugteren D. H., Hazelhof E. Isolation and properties of intermediates in prostaglandin biosynthesis. Biochim Biophys Acta. 1973 Dec 20;326(3):448–461. doi: 10.1016/0005-2760(73)90145-8. [DOI] [PubMed] [Google Scholar]
  18. Orange R. P., Austen K. F. Slow reacting substance of anaphylaxis. Adv Immunol. 1969;10:105–144. doi: 10.1016/s0065-2776(08)60416-2. [DOI] [PubMed] [Google Scholar]
  19. Orange R. P., Murphy R. C., Karnovsky M. L., Austen K. F. The physicochemical characteristics and purification of slow-reacting substance of anaphylaxis. J Immunol. 1973 Mar;110(3):760–770. [PubMed] [Google Scholar]
  20. Strandberg K., Uvnäs B. Purification and properties of the slow reacting substance formed in the cat paw perfused with compound 48-80. Acta Physiol Scand. 1971 Jul;82(3):358–374. doi: 10.1111/j.1748-1716.1971.tb04977.x. [DOI] [PubMed] [Google Scholar]
  21. Takahashi H., Webster M. E., Newball H. H. Separation of slow reacting substance of anaphylaxis (SRS-A) from human lung into four biologically active fractions. J Immunol. 1976 Sep;117(3):1039–1044. [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES